Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)
Amylase; Lipase; Protease
Essential Pharma Ltd
A09AA02
Amylase; Lipase; Protease
9000unit ; 8000unit ; 430unit
Oral capsule
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: 01090400; GTIN: 5015001142029
Pan340mgCap-LPL-UK-4 Pan340mgCap-LPL-UK-4 Pan340mgCap-LPL-UK-4 P P EAN CODE 5060312430068 EAN CODE 5060312430068 BN: EXP: 300 CAPSULES 300 CA P SU LES Ea ch capsule contains 340 mg pancreatin to provide enzymatic activity per capsule n ot less than: Free protease 430 BP Units Lipase 8000 BP Units Amylase 9000 BP Units Pancreatic enzymes for digestive support. Oral use. Read the package leaflet before use. DOSE: I nfants: The contents of 1-2 capsules mixed tho roughly with feeds. Older Children and Adults: 2-6 ca psules 4 times daily swallowed whole with meals. When mixed with liquids use within one hour. Store in a refrigerator. Ea ch capsule contains 340 mg pancreatin to provide enzymatic activity per capsule n ot less than: Fre e protease 43 0 BP Units Li pase 80 00 BP Units Am ylase 90 00 BP Units Pancreatic enzymes for digestive support. Oral use. Read the package leaflet before use. DO SE: Infants: The contents of 1-2 capsules m ixed thoroughly with feeds. Older Children and Adults: 2-6 ca psules 4 times daily swallowed whole with meals. When mixed with liquids use within one hour. Store in a refrigerator. _PACKAGE LEAFLET: INFORMATION FOR THE USER_ PANCREX V 340 MG HARD CAPSULES pancreatin The full name of this medicine is “Pancrex V 340 mg hard capsules”. The short form of the name “Pancrex V” is used throughout the remainder of the package leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What Pancrex V is and what it is used for 2. What you need to Belgenin tamamını okuyun
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pancrex V 340 mg hard capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 340 mg pancreatin to provide enzymatic activity per capsule not less than: Free protease 430 BP units Lipase 8000 BP units Amylase 9000 BP units For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Hard capsule (capsule). A white or buff coloured powder in ivory coloured opaque hard gelatin capsules imprinted Pancrex V and the company logo. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pancrex V is used to compensate for reduced intestinal enzyme activity in pancreatic deficiency states. It is indicated for the treatment of fibrocystic disease of the pancreas (cystic fibrosis), chronic pancreatitis and pancreatic steatorrhoea following pancreatectomy. It may also be indicated following gastrectomy as an aid to digestion. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Dosage should be adjusted according to the needs of the individual patient and the amount and type of food consumed. The following dosage ranges provide a suitable basis for adjustment. Infants: the contents of 1 - 2 capsules mixed with feeds. Older Children and Adults: the contents of 2 - 6 capsules with each snack or meal. The capsules may be swallowed. The capsules may provide a suitable alternative to the enteric coated presentations in cases where the pH of the duodenum is not sufficiently alkaline to dissolve the enteric coat. _Paediatric population _ Capsules provide a simple and convenient method of dose measurement of pancreatin for administration to younger children requiring a low dose. Method of administration Oral use. The capsules should be taken with each feed or meal or snack. If the capsule contents are mixed with liquids or feeds the resulting mixture should not be allowed to stand for more than one hour prior to use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIA Belgenin tamamını okuyun